MEDLIVE (02192) Proposes Appointment of Deloitte as New Auditor

Stock News
Apr 17

MEDLIVE (02192) has announced that Ernst & Young is scheduled to retire as the company's auditor following the conclusion of the Annual General Meeting on May 15, 2026. As the company and its current auditor, Ernst & Young, were unable to reach an agreement on the audit fees for the financial year ending December 31, 2026, MEDLIVE initiated a tender process for a new external auditor in March 2026. Following the recommendation of the company's audit committee on April 17, 2026, the Board of Directors has resolved to propose the appointment of Deloitte Touche Tohmatsu as the new auditor. This appointment is intended to be effective from the conclusion of the 2026 Annual General Meeting until the end of the next subsequent Annual General Meeting. The proposed appointment is subject to approval by shareholders at the 2026 Annual General Meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10